Podcast METHYLOMIC Matters - Omicrohn's Rapid Assay Development

 

Methylomic Matters is a podcastseries by the METHYLOMIC project: a program committed to bringing personalised treatment-selection in Crohn’s disease and other immune-mediated inflammatory diseases to clinical practice. In this podcastseries our host Dr. Vincent Joustra discusses several topics on DNA-methylation, machine based learning and how to bring these techniques to clinical practice.

In the fourth episode of METHYLOMIC matters our attention centers on a crucial element of METHYLOMIC: the development of an easy-to-use diagnostic test intended for clinical validation, with the ultimate aim of global adoption in medical centers. With Dr. Peter Henneman and Dr. Jules Petit we discuss the importance of a rapid assay and compare its pros and cons opposed to the current EPIC array methodology. All this and more in the fourth episode of METHYLOMIC matters!

Listen to the podcast

You can listen to the METHYLOMIC podcast through one of the below podcast channels:

Spotify   Podimo   Apple   Pca.st

Podcast METHYLOMIC Matters - Machine Learning Magic Behind the Treatment Response

 

Methylomic Matters is a podcastseries by the METHYLOMIC project: a program committed to bringing personalised treatment-selection in Crohn’s disease and other immune-mediated inflammatory diseases to clinical practice. In this podcastseries our host Dr. Vincent Joustra discusses several topics on DNA-methylation, machine based learning and how to bring these techniques to clinical practice.

In the third episode of METHYLOMIC matters we delve into the intricate machine learning methodology behind the successful prediction models developed by HORAIZON’s founder and CEO, dr. Evgeni Levin. We explore essential elements of the methodology, comparing linear and non-linear models, emphasizing the significance of multivariate models, and addressing strategies for mitigating overfitting. Furthermore, we delve into the prospective clinical applications of these models and their ultimate integration into clinical practice. All this and more in the third episode of METHYLOMIC matters!

Listen to the podcast

You can listen to the METHYLOMIC podcast through one of the below podcast channels:

Spotify   Apple podcasts   Radionet   Pocketcast

Podcast METHYLOMIC Matters - Results from the EPIC-CD project

 

Methylomic Matters is a podcastseries by the METHYLOMIC project: a program committed to bringing personalised treatment-selection in Crohn’s disease and other immune-mediated inflammatory diseases to clinical practice. In this podcastseries our host Dr. Vincent Joustra discusses several topics on DNA-methylation, machine based learning and how to bring these techniques to clinical practice.

In the second episode of METHYLOMIC matters we have the privilege of conversing with Professor Geert D’Haens and Dr. Andrew Li Yim as we delve into the pre-METHYLOMIC era and discover the science behind the OMICROHN trial: the EPIC-CD study. How did we design this biomarker discovery study and what are key important methodological steps? What were the main results and how do we envision the future? All this and more in the second episode of METHYLOMIC matters!

Listen to the podcast

You can listen to the METHYLOMIC podcast through one of the below podcast channels:

Spotify   Apple Podcasts   Podcast Republic   Google Podcasts

Podcast METHYLOMIC Matters - The concept of DNA methylation in Inflammatory Bowel Disease

Methylomic Matters is a podcastseries by the METHYLOMIC project: a program committed to bringing personalised treatment-selection in Crohn’s disease and other immune-mediated inflammatory diseases to clinical practice. In this podcastseries our host Dr. Vincent Joustra discusses several topics on DNA-methylation, machine based learning and how to bring these techniques to clinical practice.

In the first episode of METHYLOMIC matters we will speak with dr. Anje te Velde and Professor Wouter de Jonge, diving into the concept of DNA methylation changes in IBD and their potential to be used as biomarkers of therapy response in IBD. What is epigenetics and how does it work? Why is DNA methylation interesting in complex immune mediated diseases and what is the history behind the EPIC-CD and METHYLOMIC projects? All this and more in the first episode of METHYLOMIC matters!

Listen to the podcast

You can listen to the METHYLOMIC podcast through one of the below podcast channels:

Spotify   Apple   Rephonic   Podcast Republic

Goodpods   Overcast    Pca.st

Bericht 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis laoreet sit amet velit quis tempor. Integer lectus nunc, semper non tempor non, aliquet gravida purus. Mauris enim velit, pharetra in lorem nec, laoreet tincidunt sem. Suspendisse venenatis mi et tellus scelerisque mattis. Nulla augue ligula, porttitor eget mauris at, volutpat molestie justo. Cras at ornare risus. Quisque vestibulum, metus ac molestie sollicitudin, nunc mauris pharetra tortor, et blandit nulla lectus non neque. Sed iaculis, arcu in varius tincidunt, diam metus elementum diam, id gravida turpis nunc vitae ligula. Donec vestibulum venenatis massa, ut sollicitudin turpis posuere at. Phasellus finibus neque in dui fringilla luctus. Sed felis lorem, suscipit ac dui sit amet, eleifend lacinia nisi. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Nunc at enim quam. Nulla cursus in odio at accumsan. Donec lacinia malesuada diam, non condimentum sapien dictum ac. Praesent lectus sapien, blandit tristique odio non, gravida mollis risus. Vivamus euismod velit id pellentesque porttitor. Fusce euismod diam dolor, blandit ullamcorper arcu consequat eget. Nullam nec lectus lectus. Integer tempor augue quis orci pulvinar interdum. Nullam nec metus velit. Morbi at ex vulputate, varius nisi eget, volutpat urna. Duis vestibulum erat at iaculis pretium. Nullam vel aliquet tortor.

Vestibulum id posuere ante. Nulla volutpat rhoncus ex ut egestas. Maecenas non auctor arcu. Ut viverra eros vitae sapien tincidunt, at fringilla enim vulputate. Phasellus semper ac libero ac aliquam. Nulla nec efficitur tortor. Vivamus convallis ullamcorper bibendum.

Integer id mi velit. Integer elementum arcu id sem varius mattis. Curabitur viverra nulla at cursus egestas. In eget dapibus nisi. Quisque vitae augue vel elit malesuada aliquet. Sed at elementum risus, at fermentum mi. Aliquam eu urna vitae sapien vestibulum ornare. Curabitur laoreet lacus magna, at rhoncus metus ultrices congue. Nullam faucibus fermentum massa vel tempus. Vivamus rutrum erat id quam ornare, vel vehicula dolor dignissim. Aliquam id augue a nisi dictum condimentum non in risus.

Donec sed nulla hendrerit, accumsan massa nec, pretium nulla. Aliquam eget tortor lacus. Pellentesque at porta augue. Ut ut finibus ante, et congue odio. Vestibulum quis sagittis sapien. Morbi a nibh egestas, semper mi ut, luctus ligula. Vestibulum vel orci nisi. Sed ultrices imperdiet tellus at bibendum. Proin vitae lorem est. Quisque id augue sed diam ornare maximus.

Bericht 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis laoreet sit amet velit quis tempor. Integer lectus nunc, semper non tempor non, aliquet gravida purus. Mauris enim velit, pharetra in lorem nec, laoreet tincidunt sem. Suspendisse venenatis mi et tellus scelerisque mattis. Nulla augue ligula, porttitor eget mauris at, volutpat molestie justo. Cras at ornare risus. Quisque vestibulum, metus ac molestie sollicitudin, nunc mauris pharetra tortor, et blandit nulla lectus non neque. Sed iaculis, arcu in varius tincidunt, diam metus elementum diam, id gravida turpis nunc vitae ligula. Donec vestibulum venenatis massa, ut sollicitudin turpis posuere at. Phasellus finibus neque in dui fringilla luctus. Sed felis lorem, suscipit ac dui sit amet, eleifend lacinia nisi. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Nunc at enim quam. Nulla cursus in odio at accumsan. Donec lacinia malesuada diam, non condimentum sapien dictum ac. Praesent lectus sapien, blandit tristique odio non, gravida mollis risus. Vivamus euismod velit id pellentesque porttitor. Fusce euismod diam dolor, blandit ullamcorper arcu consequat eget. Nullam nec lectus lectus. Integer tempor augue quis orci pulvinar interdum. Nullam nec metus velit. Morbi at ex vulputate, varius nisi eget, volutpat urna. Duis vestibulum erat at iaculis pretium. Nullam vel aliquet tortor.

Vestibulum id posuere ante. Nulla volutpat rhoncus ex ut egestas. Maecenas non auctor arcu. Ut viverra eros vitae sapien tincidunt, at fringilla enim vulputate. Phasellus semper ac libero ac aliquam. Nulla nec efficitur tortor. Vivamus convallis ullamcorper bibendum.

Integer id mi velit. Integer elementum arcu id sem varius mattis. Curabitur viverra nulla at cursus egestas. In eget dapibus nisi. Quisque vitae augue vel elit malesuada aliquet. Sed at elementum risus, at fermentum mi. Aliquam eu urna vitae sapien vestibulum ornare. Curabitur laoreet lacus magna, at rhoncus metus ultrices congue. Nullam faucibus fermentum massa vel tempus. Vivamus rutrum erat id quam ornare, vel vehicula dolor dignissim. Aliquam id augue a nisi dictum condimentum non in risus.

Donec sed nulla hendrerit, accumsan massa nec, pretium nulla. Aliquam eget tortor lacus. Pellentesque at porta augue. Ut ut finibus ante, et congue odio. Vestibulum quis sagittis sapien. Morbi a nibh egestas, semper mi ut, luctus ligula. Vestibulum vel orci nisi. Sed ultrices imperdiet tellus at bibendum. Proin vitae lorem est. Quisque id augue sed diam ornare maximus.